High-risk COVID-19 patients may be able to receive early remdesivir treatment at a Las Vegas clinic, one of 65 in the world offering the recently approved drug in an outpatient setting as part of an ongoing trial.
High-risk COVID-19 patients may be able to receive early remdesivir treatment at a Las Vegas clinic, one of 65 in the world offering the recently approved drug in an outpatient setting as part of an ongoing trial.